在高白细胞急性髓性白血病中应用G-CSF是一个不良的预后因素
Ping Weng1, Shu Yang1, Shujuan Xu1
1Fujian Provincial Key Laboratory on Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.
Hematology (Amsterdam, Netherlands)
|June 6, 2023
概括
在急性髓性白血病 (AML) 患者中使用花细胞殖民地刺激因子 (G-CSF) 具有高白细胞计数的患者可能会缩短缓解和存活时间. 建议在给这些AML患者使用G-CSF时谨慎使用.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- 急性髓性白血病 (AML) 是一种严重的血液性恶性瘤.
- 针对AML的治疗策略旨在提高缓解率和生存率.
- 颗粒细胞殖民地刺激因子 (G-CSF) 是一种用于癌症治疗的细胞因子.
研究的目的:
- 研究G-CSF对AML患者治疗结果的影响.
- 评估G-CSF对完全缓解和整体存活时间的影响.
- 评估高白细胞计数接受G-CSF的AML患者的结局.
主要方法:
- 分析了526名AML患者的队列.
- 患者被分为G-CSF治疗 (355) 和未治疗 (171) 组.
- 考克斯回归和卡普兰-梅尔分析被用来评估CR1和OS.
主要成果:
- G-CSF的使用与第一个完全缓解 (CR1) 阶段的显著缩短有关.
- 在接受G-CSF的患者中,整体存活率 (OS) 也显著降低.
- 这些效应特别在初始白血球数量高的患者中被注意到.
结论:
- 在AML患者中,G-CSF应谨慎使用.
- 在AML患者呈现高白细胞计数时,需要特别小心.
- 这些发现表明,G-CSF在特定的AML亚群中可能会产生负面影响.
更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.0K
12:05Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
11.7K
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Disorders of Leukocytes
989
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
989
